Search

Your search keyword '"Harrington, Susan M"' showing total 43 results
Start Over Author "Harrington, Susan M" Publisher american association for cancer research (aacr)
43 results on '"Harrington, Susan M"'

1. Supplementary Figure from NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy

Author

Wen, Ti, primary, Barham, Whitney, primary, Li, Ying, primary, Zhang, Henan, primary, Gicobi, Joanina K., primary, Hirdler, Jacob B., primary, Liu, Xin, primary, Ham, Hyoungjun, primary, Peterson Martinez, Kodi E., primary, Lucien, Fabrice, primary, Lavoie, Roxane R., primary, Li, Hu, primary, Correia, Cristina, primary, Monie, Dileep D., primary, An, Zesheng, primary, Harrington, Susan M., primary, Wu, Xiaosheng, primary, Guo, Ruifeng, primary, Dronca, Roxana S., primary, Mansfield, Aaron S., primary, Yan, Yiyi, primary, Markovic, Svetomir N., primary, Park, Sean S., primary, Sun, Jie, primary, Qin, Hong, primary, Liu, Minetta C., primary, Vasmatzis, George, primary, Billadeau, Daniel D., primary, and Dong, Haidong, primary

Published
2024
Full Text
View/download PDF

2. Supplementary Data from NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy

Author

Wen, Ti, primary, Barham, Whitney, primary, Li, Ying, primary, Zhang, Henan, primary, Gicobi, Joanina K., primary, Hirdler, Jacob B., primary, Liu, Xin, primary, Ham, Hyoungjun, primary, Peterson Martinez, Kodi E., primary, Lucien, Fabrice, primary, Lavoie, Roxane R., primary, Li, Hu, primary, Correia, Cristina, primary, Monie, Dileep D., primary, An, Zesheng, primary, Harrington, Susan M., primary, Wu, Xiaosheng, primary, Guo, Ruifeng, primary, Dronca, Roxana S., primary, Mansfield, Aaron S., primary, Yan, Yiyi, primary, Markovic, Svetomir N., primary, Park, Sean S., primary, Sun, Jie, primary, Qin, Hong, primary, Liu, Minetta C., primary, Vasmatzis, George, primary, Billadeau, Daniel D., primary, and Dong, Haidong, primary

Published
2024
Full Text
View/download PDF

3. Supplementary Data from NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy

Author

Wen, Ti, primary, Barham, Whitney, primary, Li, Ying, primary, Zhang, Henan, primary, Gicobi, Joanina K., primary, Hirdler, Jacob B., primary, Liu, Xin, primary, Ham, Hyoungjun, primary, Peterson Martinez, Kodi E., primary, Lucien, Fabrice, primary, Lavoie, Roxane R., primary, Li, Hu, primary, Correia, Cristina, primary, Monie, Dileep D., primary, An, Zesheng, primary, Harrington, Susan M., primary, Wu, Xiaosheng, primary, Guo, Ruifeng, primary, Dronca, Roxana S., primary, Mansfield, Aaron S., primary, Yan, Yiyi, primary, Markovic, Svetomir N., primary, Park, Sean S., primary, Sun, Jie, primary, Qin, Hong, primary, Liu, Minetta C., primary, Vasmatzis, George, primary, Billadeau, Daniel D., primary, and Dong, Haidong, primary

Published
2024
Full Text
View/download PDF

4. Supplementary Figure from NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy

Author

Wen, Ti, primary, Barham, Whitney, primary, Li, Ying, primary, Zhang, Henan, primary, Gicobi, Joanina K., primary, Hirdler, Jacob B., primary, Liu, Xin, primary, Ham, Hyoungjun, primary, Peterson Martinez, Kodi E., primary, Lucien, Fabrice, primary, Lavoie, Roxane R., primary, Li, Hu, primary, Correia, Cristina, primary, Monie, Dileep D., primary, An, Zesheng, primary, Harrington, Susan M., primary, Wu, Xiaosheng, primary, Guo, Ruifeng, primary, Dronca, Roxana S., primary, Mansfield, Aaron S., primary, Yan, Yiyi, primary, Markovic, Svetomir N., primary, Park, Sean S., primary, Sun, Jie, primary, Qin, Hong, primary, Liu, Minetta C., primary, Vasmatzis, George, primary, Billadeau, Daniel D., primary, and Dong, Haidong, primary

Published
2024
Full Text
View/download PDF

5. Data from NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy

Author

Wen, Ti, primary, Barham, Whitney, primary, Li, Ying, primary, Zhang, Henan, primary, Gicobi, Joanina K., primary, Hirdler, Jacob B., primary, Liu, Xin, primary, Ham, Hyoungjun, primary, Peterson Martinez, Kodi E., primary, Lucien, Fabrice, primary, Lavoie, Roxane R., primary, Li, Hu, primary, Correia, Cristina, primary, Monie, Dileep D., primary, An, Zesheng, primary, Harrington, Susan M., primary, Wu, Xiaosheng, primary, Guo, Ruifeng, primary, Dronca, Roxana S., primary, Mansfield, Aaron S., primary, Yan, Yiyi, primary, Markovic, Svetomir N., primary, Park, Sean S., primary, Sun, Jie, primary, Qin, Hong, primary, Liu, Minetta C., primary, Vasmatzis, George, primary, Billadeau, Daniel D., primary, and Dong, Haidong, primary

Published
2023
Full Text
View/download PDF

6. Supplementary Figure from NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy

Author

Wen, Ti, primary, Barham, Whitney, primary, Li, Ying, primary, Zhang, Henan, primary, Gicobi, Joanina K., primary, Hirdler, Jacob B., primary, Liu, Xin, primary, Ham, Hyoungjun, primary, Peterson Martinez, Kodi E., primary, Lucien, Fabrice, primary, Lavoie, Roxane R., primary, Li, Hu, primary, Correia, Cristina, primary, Monie, Dileep D., primary, An, Zesheng, primary, Harrington, Susan M., primary, Wu, Xiaosheng, primary, Guo, Ruifeng, primary, Dronca, Roxana S., primary, Mansfield, Aaron S., primary, Yan, Yiyi, primary, Markovic, Svetomir N., primary, Park, Sean S., primary, Sun, Jie, primary, Qin, Hong, primary, Liu, Minetta C., primary, Vasmatzis, George, primary, Billadeau, Daniel D., primary, and Dong, Haidong, primary

Published
2023
Full Text
View/download PDF

7. Supplementary Figure from NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy

Author

Wen, Ti, primary, Barham, Whitney, primary, Li, Ying, primary, Zhang, Henan, primary, Gicobi, Joanina K., primary, Hirdler, Jacob B., primary, Liu, Xin, primary, Ham, Hyoungjun, primary, Peterson Martinez, Kodi E., primary, Lucien, Fabrice, primary, Lavoie, Roxane R., primary, Li, Hu, primary, Correia, Cristina, primary, Monie, Dileep D., primary, An, Zesheng, primary, Harrington, Susan M., primary, Wu, Xiaosheng, primary, Guo, Ruifeng, primary, Dronca, Roxana S., primary, Mansfield, Aaron S., primary, Yan, Yiyi, primary, Markovic, Svetomir N., primary, Park, Sean S., primary, Sun, Jie, primary, Qin, Hong, primary, Liu, Minetta C., primary, Vasmatzis, George, primary, Billadeau, Daniel D., primary, and Dong, Haidong, primary

Published
2023
Full Text
View/download PDF

8. Data from NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy

Author

Wen, Ti, primary, Barham, Whitney, primary, Li, Ying, primary, Zhang, Henan, primary, Gicobi, Joanina K., primary, Hirdler, Jacob B., primary, Liu, Xin, primary, Ham, Hyoungjun, primary, Peterson Martinez, Kodi E., primary, Lucien, Fabrice, primary, Lavoie, Roxane R., primary, Li, Hu, primary, Correia, Cristina, primary, Monie, Dileep D., primary, An, Zesheng, primary, Harrington, Susan M., primary, Wu, Xiaosheng, primary, Guo, Ruifeng, primary, Dronca, Roxana S., primary, Mansfield, Aaron S., primary, Yan, Yiyi, primary, Markovic, Svetomir N., primary, Park, Sean S., primary, Sun, Jie, primary, Qin, Hong, primary, Liu, Minetta C., primary, Vasmatzis, George, primary, Billadeau, Daniel D., primary, and Dong, Haidong, primary

Published
2023
Full Text
View/download PDF

9. Supplementary Data from NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy

Author

Wen, Ti, primary, Barham, Whitney, primary, Li, Ying, primary, Zhang, Henan, primary, Gicobi, Joanina K., primary, Hirdler, Jacob B., primary, Liu, Xin, primary, Ham, Hyoungjun, primary, Peterson Martinez, Kodi E., primary, Lucien, Fabrice, primary, Lavoie, Roxane R., primary, Li, Hu, primary, Correia, Cristina, primary, Monie, Dileep D., primary, An, Zesheng, primary, Harrington, Susan M., primary, Wu, Xiaosheng, primary, Guo, Ruifeng, primary, Dronca, Roxana S., primary, Mansfield, Aaron S., primary, Yan, Yiyi, primary, Markovic, Svetomir N., primary, Park, Sean S., primary, Sun, Jie, primary, Qin, Hong, primary, Liu, Minetta C., primary, Vasmatzis, George, primary, Billadeau, Daniel D., primary, and Dong, Haidong, primary

Published
2023
Full Text
View/download PDF

10. Supplementary Data from NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy

Author

Wen, Ti, primary, Barham, Whitney, primary, Li, Ying, primary, Zhang, Henan, primary, Gicobi, Joanina K., primary, Hirdler, Jacob B., primary, Liu, Xin, primary, Ham, Hyoungjun, primary, Peterson Martinez, Kodi E., primary, Lucien, Fabrice, primary, Lavoie, Roxane R., primary, Li, Hu, primary, Correia, Cristina, primary, Monie, Dileep D., primary, An, Zesheng, primary, Harrington, Susan M., primary, Wu, Xiaosheng, primary, Guo, Ruifeng, primary, Dronca, Roxana S., primary, Mansfield, Aaron S., primary, Yan, Yiyi, primary, Markovic, Svetomir N., primary, Park, Sean S., primary, Sun, Jie, primary, Qin, Hong, primary, Liu, Minetta C., primary, Vasmatzis, George, primary, Billadeau, Daniel D., primary, and Dong, Haidong, primary

Published
2023
Full Text
View/download PDF

15. Data from PD-1 Restrains Radiotherapy-Induced Abscopal Effect

Author

Park, Sean S., primary, Dong, Haidong, primary, Liu, Xin, primary, Harrington, Susan M., primary, Krco, Christopher J., primary, Grams, Michael P., primary, Mansfield, Aaron S., primary, Furutani, Keith M., primary, Olivier, Kenneth R., primary, and Kwon, Eugene D., primary

Published
2023
Full Text
View/download PDF

16. Data from PD-1 Restrains Radiotherapy-Induced Abscopal Effect

Author

Park, Sean S., primary, Dong, Haidong, primary, Liu, Xin, primary, Harrington, Susan M., primary, Krco, Christopher J., primary, Grams, Michael P., primary, Mansfield, Aaron S., primary, Furutani, Keith M., primary, Olivier, Kenneth R., primary, and Kwon, Eugene D., primary

Published
2023
Full Text
View/download PDF

17. Supplementary Figure from Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction

Author

Zhu, Mojun, primary, Chen, Chunhua, primary, Foster, Nathan R., primary, Hartley, Christopher, primary, Mounajjed, Taofic, primary, Salomao, Marcela A., primary, Fruth, Briant F., primary, Beamer, Staci E., primary, Kim, Yohan, primary, Harrington, Susan M., primary, Pitot, Henry C., primary, Sanhueza, Cristobal T., primary, Feng, Yening, primary, Herrmann, Joerg, primary, McWilliams, Robert R., primary, Lucien, Fabrice, primary, Huang, Bing Q., primary, Ma, Wen Wee, primary, Bekaii-Saab, Tanios S., primary, Dong, Haidong, primary, Wigle, Dennis, primary, Ahn, Daniel H., primary, Hallemeier, Chris L., primary, Blackmon, Shanda, primary, and Yoon, Harry H., primary

Published
2023
Full Text
View/download PDF

18. Supplementary Figure from Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction

Author

Zhu, Mojun, primary, Chen, Chunhua, primary, Foster, Nathan R., primary, Hartley, Christopher, primary, Mounajjed, Taofic, primary, Salomao, Marcela A., primary, Fruth, Briant F., primary, Beamer, Staci E., primary, Kim, Yohan, primary, Harrington, Susan M., primary, Pitot, Henry C., primary, Sanhueza, Cristobal T., primary, Feng, Yening, primary, Herrmann, Joerg, primary, McWilliams, Robert R., primary, Lucien, Fabrice, primary, Huang, Bing Q., primary, Ma, Wen Wee, primary, Bekaii-Saab, Tanios S., primary, Dong, Haidong, primary, Wigle, Dennis, primary, Ahn, Daniel H., primary, Hallemeier, Chris L., primary, Blackmon, Shanda, primary, and Yoon, Harry H., primary

Published
2023
Full Text
View/download PDF

19. Supplementary Data from Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction

Author

Zhu, Mojun, primary, Chen, Chunhua, primary, Foster, Nathan R., primary, Hartley, Christopher, primary, Mounajjed, Taofic, primary, Salomao, Marcela A., primary, Fruth, Briant F., primary, Beamer, Staci E., primary, Kim, Yohan, primary, Harrington, Susan M., primary, Pitot, Henry C., primary, Sanhueza, Cristobal T., primary, Feng, Yening, primary, Herrmann, Joerg, primary, McWilliams, Robert R., primary, Lucien, Fabrice, primary, Huang, Bing Q., primary, Ma, Wen Wee, primary, Bekaii-Saab, Tanios S., primary, Dong, Haidong, primary, Wigle, Dennis, primary, Ahn, Daniel H., primary, Hallemeier, Chris L., primary, Blackmon, Shanda, primary, and Yoon, Harry H., primary

Published
2023
Full Text
View/download PDF

20. Supplementary Table from Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction

Author

Zhu, Mojun, primary, Chen, Chunhua, primary, Foster, Nathan R., primary, Hartley, Christopher, primary, Mounajjed, Taofic, primary, Salomao, Marcela A., primary, Fruth, Briant F., primary, Beamer, Staci E., primary, Kim, Yohan, primary, Harrington, Susan M., primary, Pitot, Henry C., primary, Sanhueza, Cristobal T., primary, Feng, Yening, primary, Herrmann, Joerg, primary, McWilliams, Robert R., primary, Lucien, Fabrice, primary, Huang, Bing Q., primary, Ma, Wen Wee, primary, Bekaii-Saab, Tanios S., primary, Dong, Haidong, primary, Wigle, Dennis, primary, Ahn, Daniel H., primary, Hallemeier, Chris L., primary, Blackmon, Shanda, primary, and Yoon, Harry H., primary

Published
2023
Full Text
View/download PDF

21. Data from Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction

Author

Zhu, Mojun, primary, Chen, Chunhua, primary, Foster, Nathan R., primary, Hartley, Christopher, primary, Mounajjed, Taofic, primary, Salomao, Marcela A., primary, Fruth, Briant F., primary, Beamer, Staci E., primary, Kim, Yohan, primary, Harrington, Susan M., primary, Pitot, Henry C., primary, Sanhueza, Cristobal T., primary, Feng, Yening, primary, Herrmann, Joerg, primary, McWilliams, Robert R., primary, Lucien, Fabrice, primary, Huang, Bing Q., primary, Ma, Wen Wee, primary, Bekaii-Saab, Tanios S., primary, Dong, Haidong, primary, Wigle, Dennis, primary, Ahn, Daniel H., primary, Hallemeier, Chris L., primary, Blackmon, Shanda, primary, and Yoon, Harry H., primary

Published
2023
Full Text
View/download PDF

22. Supplementary Figure from Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction

Author

Zhu, Mojun, primary, Chen, Chunhua, primary, Foster, Nathan R., primary, Hartley, Christopher, primary, Mounajjed, Taofic, primary, Salomao, Marcela A., primary, Fruth, Briant F., primary, Beamer, Staci E., primary, Kim, Yohan, primary, Harrington, Susan M., primary, Pitot, Henry C., primary, Sanhueza, Cristobal T., primary, Feng, Yening, primary, Herrmann, Joerg, primary, McWilliams, Robert R., primary, Lucien, Fabrice, primary, Huang, Bing Q., primary, Ma, Wen Wee, primary, Bekaii-Saab, Tanios S., primary, Dong, Haidong, primary, Wigle, Dennis, primary, Ahn, Daniel H., primary, Hallemeier, Chris L., primary, Blackmon, Shanda, primary, and Yoon, Harry H., primary

Published
2023
Full Text
View/download PDF

23. Supplementary Table from Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction

Author

Zhu, Mojun, primary, Chen, Chunhua, primary, Foster, Nathan R., primary, Hartley, Christopher, primary, Mounajjed, Taofic, primary, Salomao, Marcela A., primary, Fruth, Briant F., primary, Beamer, Staci E., primary, Kim, Yohan, primary, Harrington, Susan M., primary, Pitot, Henry C., primary, Sanhueza, Cristobal T., primary, Feng, Yening, primary, Herrmann, Joerg, primary, McWilliams, Robert R., primary, Lucien, Fabrice, primary, Huang, Bing Q., primary, Ma, Wen Wee, primary, Bekaii-Saab, Tanios S., primary, Dong, Haidong, primary, Wigle, Dennis, primary, Ahn, Daniel H., primary, Hallemeier, Chris L., primary, Blackmon, Shanda, primary, and Yoon, Harry H., primary

Published
2023
Full Text
View/download PDF

24. Supplementary Data from Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction

Author

Zhu, Mojun, primary, Chen, Chunhua, primary, Foster, Nathan R., primary, Hartley, Christopher, primary, Mounajjed, Taofic, primary, Salomao, Marcela A., primary, Fruth, Briant F., primary, Beamer, Staci E., primary, Kim, Yohan, primary, Harrington, Susan M., primary, Pitot, Henry C., primary, Sanhueza, Cristobal T., primary, Feng, Yening, primary, Herrmann, Joerg, primary, McWilliams, Robert R., primary, Lucien, Fabrice, primary, Huang, Bing Q., primary, Ma, Wen Wee, primary, Bekaii-Saab, Tanios S., primary, Dong, Haidong, primary, Wigle, Dennis, primary, Ahn, Daniel H., primary, Hallemeier, Chris L., primary, Blackmon, Shanda, primary, and Yoon, Harry H., primary

Published
2023
Full Text
View/download PDF

25. Supplementary Figure from Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction

Author

Zhu, Mojun, primary, Chen, Chunhua, primary, Foster, Nathan R., primary, Hartley, Christopher, primary, Mounajjed, Taofic, primary, Salomao, Marcela A., primary, Fruth, Briant F., primary, Beamer, Staci E., primary, Kim, Yohan, primary, Harrington, Susan M., primary, Pitot, Henry C., primary, Sanhueza, Cristobal T., primary, Feng, Yening, primary, Herrmann, Joerg, primary, McWilliams, Robert R., primary, Lucien, Fabrice, primary, Huang, Bing Q., primary, Ma, Wen Wee, primary, Bekaii-Saab, Tanios S., primary, Dong, Haidong, primary, Wigle, Dennis, primary, Ahn, Daniel H., primary, Hallemeier, Chris L., primary, Blackmon, Shanda, primary, and Yoon, Harry H., primary

Published
2023
Full Text
View/download PDF

26. Supplementary Figure from Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction

Author

Zhu, Mojun, primary, Chen, Chunhua, primary, Foster, Nathan R., primary, Hartley, Christopher, primary, Mounajjed, Taofic, primary, Salomao, Marcela A., primary, Fruth, Briant F., primary, Beamer, Staci E., primary, Kim, Yohan, primary, Harrington, Susan M., primary, Pitot, Henry C., primary, Sanhueza, Cristobal T., primary, Feng, Yening, primary, Herrmann, Joerg, primary, McWilliams, Robert R., primary, Lucien, Fabrice, primary, Huang, Bing Q., primary, Ma, Wen Wee, primary, Bekaii-Saab, Tanios S., primary, Dong, Haidong, primary, Wigle, Dennis, primary, Ahn, Daniel H., primary, Hallemeier, Chris L., primary, Blackmon, Shanda, primary, and Yoon, Harry H., primary

Published
2023
Full Text
View/download PDF

27. Supplementary Figure from Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction

Author

Zhu, Mojun, primary, Chen, Chunhua, primary, Foster, Nathan R., primary, Hartley, Christopher, primary, Mounajjed, Taofic, primary, Salomao, Marcela A., primary, Fruth, Briant F., primary, Beamer, Staci E., primary, Kim, Yohan, primary, Harrington, Susan M., primary, Pitot, Henry C., primary, Sanhueza, Cristobal T., primary, Feng, Yening, primary, Herrmann, Joerg, primary, McWilliams, Robert R., primary, Lucien, Fabrice, primary, Huang, Bing Q., primary, Ma, Wen Wee, primary, Bekaii-Saab, Tanios S., primary, Dong, Haidong, primary, Wigle, Dennis, primary, Ahn, Daniel H., primary, Hallemeier, Chris L., primary, Blackmon, Shanda, primary, and Yoon, Harry H., primary

Published
2023
Full Text
View/download PDF

28. Supplementary Figure from Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction

Author

Zhu, Mojun, primary, Chen, Chunhua, primary, Foster, Nathan R., primary, Hartley, Christopher, primary, Mounajjed, Taofic, primary, Salomao, Marcela A., primary, Fruth, Briant F., primary, Beamer, Staci E., primary, Kim, Yohan, primary, Harrington, Susan M., primary, Pitot, Henry C., primary, Sanhueza, Cristobal T., primary, Feng, Yening, primary, Herrmann, Joerg, primary, McWilliams, Robert R., primary, Lucien, Fabrice, primary, Huang, Bing Q., primary, Ma, Wen Wee, primary, Bekaii-Saab, Tanios S., primary, Dong, Haidong, primary, Wigle, Dennis, primary, Ahn, Daniel H., primary, Hallemeier, Chris L., primary, Blackmon, Shanda, primary, and Yoon, Harry H., primary

Published
2023
Full Text
View/download PDF

29. Supplementary Figure from Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction

Author

Zhu, Mojun, primary, Chen, Chunhua, primary, Foster, Nathan R., primary, Hartley, Christopher, primary, Mounajjed, Taofic, primary, Salomao, Marcela A., primary, Fruth, Briant F., primary, Beamer, Staci E., primary, Kim, Yohan, primary, Harrington, Susan M., primary, Pitot, Henry C., primary, Sanhueza, Cristobal T., primary, Feng, Yening, primary, Herrmann, Joerg, primary, McWilliams, Robert R., primary, Lucien, Fabrice, primary, Huang, Bing Q., primary, Ma, Wen Wee, primary, Bekaii-Saab, Tanios S., primary, Dong, Haidong, primary, Wigle, Dennis, primary, Ahn, Daniel H., primary, Hallemeier, Chris L., primary, Blackmon, Shanda, primary, and Yoon, Harry H., primary

Published
2023
Full Text
View/download PDF

30. Supplementary Table from Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction

Author

Zhu, Mojun, primary, Chen, Chunhua, primary, Foster, Nathan R., primary, Hartley, Christopher, primary, Mounajjed, Taofic, primary, Salomao, Marcela A., primary, Fruth, Briant F., primary, Beamer, Staci E., primary, Kim, Yohan, primary, Harrington, Susan M., primary, Pitot, Henry C., primary, Sanhueza, Cristobal T., primary, Feng, Yening, primary, Herrmann, Joerg, primary, McWilliams, Robert R., primary, Lucien, Fabrice, primary, Huang, Bing Q., primary, Ma, Wen Wee, primary, Bekaii-Saab, Tanios S., primary, Dong, Haidong, primary, Wigle, Dennis, primary, Ahn, Daniel H., primary, Hallemeier, Chris L., primary, Blackmon, Shanda, primary, and Yoon, Harry H., primary

Published
2023
Full Text
View/download PDF

31. Supplementary Table from Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction

Author

Zhu, Mojun, primary, Chen, Chunhua, primary, Foster, Nathan R., primary, Hartley, Christopher, primary, Mounajjed, Taofic, primary, Salomao, Marcela A., primary, Fruth, Briant F., primary, Beamer, Staci E., primary, Kim, Yohan, primary, Harrington, Susan M., primary, Pitot, Henry C., primary, Sanhueza, Cristobal T., primary, Feng, Yening, primary, Herrmann, Joerg, primary, McWilliams, Robert R., primary, Lucien, Fabrice, primary, Huang, Bing Q., primary, Ma, Wen Wee, primary, Bekaii-Saab, Tanios S., primary, Dong, Haidong, primary, Wigle, Dennis, primary, Ahn, Daniel H., primary, Hallemeier, Chris L., primary, Blackmon, Shanda, primary, and Yoon, Harry H., primary

Published
2023
Full Text
View/download PDF

32. Legend for Supplemental Figure 2legend from Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma

Author

Gustafson, Michael P., primary, Lin, Yi, primary, Bleeker, Jonathan S., primary, Warad, Deepti, primary, Tollefson, Matthew K., primary, Crispen, Paul L., primary, Bulur, Peggy A., primary, Harrington, Susan M., primary, Laborde, Rebecca R., primary, Gastineau, Dennis A., primary, Leibovich, Bradley C., primary, Cheville, John C., primary, Kwon, Eugene D., primary, and Dietz, Allan B., primary

Published
2023
Full Text
View/download PDF

33. Supplementary Figure from Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction

Author

Zhu, Mojun, primary, Chen, Chunhua, primary, Foster, Nathan R., primary, Hartley, Christopher, primary, Mounajjed, Taofic, primary, Salomao, Marcela A., primary, Fruth, Briant F., primary, Beamer, Staci E., primary, Kim, Yohan, primary, Harrington, Susan M., primary, Pitot, Henry C., primary, Sanhueza, Cristobal T., primary, Feng, Yening, primary, Herrmann, Joerg, primary, McWilliams, Robert R., primary, Lucien, Fabrice, primary, Huang, Bing Q., primary, Ma, Wen Wee, primary, Bekaii-Saab, Tanios S., primary, Dong, Haidong, primary, Wigle, Dennis, primary, Ahn, Daniel H., primary, Hallemeier, Chris L., primary, Blackmon, Shanda, primary, and Yoon, Harry H., primary

Published
2023
Full Text
View/download PDF

34. Supplementary Figure from Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction

Author

Zhu, Mojun, primary, Chen, Chunhua, primary, Foster, Nathan R., primary, Hartley, Christopher, primary, Mounajjed, Taofic, primary, Salomao, Marcela A., primary, Fruth, Briant F., primary, Beamer, Staci E., primary, Kim, Yohan, primary, Harrington, Susan M., primary, Pitot, Henry C., primary, Sanhueza, Cristobal T., primary, Feng, Yening, primary, Herrmann, Joerg, primary, McWilliams, Robert R., primary, Lucien, Fabrice, primary, Huang, Bing Q., primary, Ma, Wen Wee, primary, Bekaii-Saab, Tanios S., primary, Dong, Haidong, primary, Wigle, Dennis, primary, Ahn, Daniel H., primary, Hallemeier, Chris L., primary, Blackmon, Shanda, primary, and Yoon, Harry H., primary

Published
2023
Full Text
View/download PDF

35. Data from Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction

Author

Zhu, Mojun, primary, Chen, Chunhua, primary, Foster, Nathan R., primary, Hartley, Christopher, primary, Mounajjed, Taofic, primary, Salomao, Marcela A., primary, Fruth, Briant F., primary, Beamer, Staci E., primary, Kim, Yohan, primary, Harrington, Susan M., primary, Pitot, Henry C., primary, Sanhueza, Cristobal T., primary, Feng, Yening, primary, Herrmann, Joerg, primary, McWilliams, Robert R., primary, Lucien, Fabrice, primary, Huang, Bing Q., primary, Ma, Wen Wee, primary, Bekaii-Saab, Tanios S., primary, Dong, Haidong, primary, Wigle, Dennis, primary, Ahn, Daniel H., primary, Hallemeier, Chris L., primary, Blackmon, Shanda, primary, and Yoon, Harry H., primary

Published
2023
Full Text
View/download PDF

36. Supplementary Figure from Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction

Author

Zhu, Mojun, primary, Chen, Chunhua, primary, Foster, Nathan R., primary, Hartley, Christopher, primary, Mounajjed, Taofic, primary, Salomao, Marcela A., primary, Fruth, Briant F., primary, Beamer, Staci E., primary, Kim, Yohan, primary, Harrington, Susan M., primary, Pitot, Henry C., primary, Sanhueza, Cristobal T., primary, Feng, Yening, primary, Herrmann, Joerg, primary, McWilliams, Robert R., primary, Lucien, Fabrice, primary, Huang, Bing Q., primary, Ma, Wen Wee, primary, Bekaii-Saab, Tanios S., primary, Dong, Haidong, primary, Wigle, Dennis, primary, Ahn, Daniel H., primary, Hallemeier, Chris L., primary, Blackmon, Shanda, primary, and Yoon, Harry H., primary

Published
2023
Full Text
View/download PDF

37. Supplementary Figure from Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction

Author

Zhu, Mojun, primary, Chen, Chunhua, primary, Foster, Nathan R., primary, Hartley, Christopher, primary, Mounajjed, Taofic, primary, Salomao, Marcela A., primary, Fruth, Briant F., primary, Beamer, Staci E., primary, Kim, Yohan, primary, Harrington, Susan M., primary, Pitot, Henry C., primary, Sanhueza, Cristobal T., primary, Feng, Yening, primary, Herrmann, Joerg, primary, McWilliams, Robert R., primary, Lucien, Fabrice, primary, Huang, Bing Q., primary, Ma, Wen Wee, primary, Bekaii-Saab, Tanios S., primary, Dong, Haidong, primary, Wigle, Dennis, primary, Ahn, Daniel H., primary, Hallemeier, Chris L., primary, Blackmon, Shanda, primary, and Yoon, Harry H., primary

Published
2023
Full Text
View/download PDF

38. Supplementary Figure from Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction

Author

Zhu, Mojun, primary, Chen, Chunhua, primary, Foster, Nathan R., primary, Hartley, Christopher, primary, Mounajjed, Taofic, primary, Salomao, Marcela A., primary, Fruth, Briant F., primary, Beamer, Staci E., primary, Kim, Yohan, primary, Harrington, Susan M., primary, Pitot, Henry C., primary, Sanhueza, Cristobal T., primary, Feng, Yening, primary, Herrmann, Joerg, primary, McWilliams, Robert R., primary, Lucien, Fabrice, primary, Huang, Bing Q., primary, Ma, Wen Wee, primary, Bekaii-Saab, Tanios S., primary, Dong, Haidong, primary, Wigle, Dennis, primary, Ahn, Daniel H., primary, Hallemeier, Chris L., primary, Blackmon, Shanda, primary, and Yoon, Harry H., primary

Published
2023
Full Text
View/download PDF

39. Supplementary Figure from Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction

Author

Zhu, Mojun, primary, Chen, Chunhua, primary, Foster, Nathan R., primary, Hartley, Christopher, primary, Mounajjed, Taofic, primary, Salomao, Marcela A., primary, Fruth, Briant F., primary, Beamer, Staci E., primary, Kim, Yohan, primary, Harrington, Susan M., primary, Pitot, Henry C., primary, Sanhueza, Cristobal T., primary, Feng, Yening, primary, Herrmann, Joerg, primary, McWilliams, Robert R., primary, Lucien, Fabrice, primary, Huang, Bing Q., primary, Ma, Wen Wee, primary, Bekaii-Saab, Tanios S., primary, Dong, Haidong, primary, Wigle, Dennis, primary, Ahn, Daniel H., primary, Hallemeier, Chris L., primary, Blackmon, Shanda, primary, and Yoon, Harry H., primary

Published
2023
Full Text
View/download PDF

40. Pembrolizumab in Combination with Neoadjuvant Chemoradiotherapy for Patients with Resectable Adenocarcinoma of the Gastroesophageal Junction

Author

Zhu, Mojun, primary, Chen, Chunhua, additional, Foster, Nathan R., additional, Hartley, Christopher, additional, Mounajjed, Taofic, additional, Salomao, Marcela A., additional, Fruth, Briant F., additional, Beamer, Staci E., additional, Kim, Yohan, additional, Harrington, Susan M., additional, Pitot, Henry C., additional, Sanhueza, Cristobal T., additional, Feng, Yening, additional, Herrmann, Joerg, additional, McWilliams, Robert R., additional, Lucien, Fabrice, additional, Huang, Bing Q., additional, Ma, Wen Wee, additional, Bekaii-Saab, Tanios S., additional, Dong, Haidong, additional, Wigle, Dennis, additional, Ahn, Daniel H., additional, Hallemeier, Chris L., additional, Blackmon, Shanda, additional, and Yoon, Harry H., additional

Published
2022
Full Text
View/download PDF

41. NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy

Author

Wen, Ti, primary, Barham, Whitney, additional, Li, Ying, additional, Zhang, Henan, additional, Gicobi, Joanina K., additional, Hirdler, Jacob B., additional, Liu, Xin, additional, Ham, Hyoungjun, additional, Peterson Martinez, Kodi E., additional, Lucien, Fabrice, additional, Lavoie, Roxane R., additional, Li, Hu, additional, Correia, Cristina, additional, Monie, Dileep D., additional, An, Zesheng, additional, Harrington, Susan M., additional, Wu, Xiaosheng, additional, Guo, Ruifeng, additional, Dronca, Roxana S., additional, Mansfield, Aaron S., additional, Yan, Yiyi, additional, Markovic, Svetomir N., additional, Park, Sean S., additional, Sun, Jie, additional, Qin, Hong, additional, Liu, Minetta C., additional, Vasmatzis, George, additional, Billadeau, Daniel D., additional, and Dong, Haidong, additional

Published
2021
Full Text
View/download PDF

42. Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma

Author

Gustafson, Michael P., primary, Lin, Yi, additional, Bleeker, Jonathan S., additional, Warad, Deepti, additional, Tollefson, Matthew K., additional, Crispen, Paul L., additional, Bulur, Peggy A., additional, Harrington, Susan M., additional, Laborde, Rebecca R., additional, Gastineau, Dennis A., additional, Leibovich, Bradley C., additional, Cheville, John C., additional, Kwon, Eugene D., additional, and Dietz, Allan B., additional

Published
2015
Full Text
View/download PDF

43. PD-1 Restrains Radiotherapy-Induced Abscopal Effect

Author

Park, Sean S., primary, Dong, Haidong, additional, Liu, Xin, additional, Harrington, Susan M., additional, Krco, Christopher J., additional, Grams, Michael P., additional, Mansfield, Aaron S., additional, Furutani, Keith M., additional, Olivier, Kenneth R., additional, and Kwon, Eugene D., additional

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results